Clinical data | |
---|---|
Trade names | Exviera, Viekira Pak, Viekira XR |
Other names | ABT-333 |
AHFS/Drugs.com | Viekira Pak Monograph Dasabuvir UK Drug Information |
MedlinePlus | a616040 |
License data | |
Routes of administration | By mouth |
ATC code | |
Legal status | |
Legal status | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.232.246 |
Chemical and physical data | |
Formula | C26H27N3O5S |
Molar mass | 493.58 g·mol−1 |
3D model (JSmol) | |
| |
|
Dasabuvir, sold under the brand name Exviera, is an antiviral medication for the treatment of hepatitis C.[3] It is often used together with the combination medication ombitasvir/paritaprevir/ritonavir specifically for hepatitis C virus (HCV) type 1.[3] Ribavirin may also additionally be used.[1][2] These combinations result in a cure in more than 90% of people.[4] It is taken by mouth.[3]
Common side effects include trouble sleeping, nausea, itchiness, and feeling tired.[4] It is not recommended in those with liver failure but appears okay in people with kidney disease.[3] While there is no evidence of harm if used during pregnancy, it has not been well studied.[3] It should not be used with birth control pills that contain ethinylestradiol.[4] Dasabuvir is in the HCV NS5B polymerase inhibitor class of medication.[3]
Dasabuvir was approved for medical use in 2014.[5] It is on the World Health Organization's List of Essential Medicines.[6] In the United States, it is approved by the Food and Drug Administration (FDA) only for use in combination with ombitasvir/paritaprevir/ritonavir.[3] As of 2015[update], the ability to get these medications in many areas of the world is poor.[7]
Viekira Pak FDA label
was invoked but never defined (see the help page).Exviera EPAR
was invoked but never defined (see the help page).